SK bioscience Co.,Ltd. (302440.KS) KSC

47,600.00

-50(-0.11%)

Updated at October 20 10:11AM

Currency In KRW

Valuation

Market Cap3.89T
Enterprise Value3.97T
P/E Ratio-70.87
PEG Ratio7.09
Price/Sales Ratio6.97
Price/Book Ratio2.08
Enterprise/Revenue7.27
Enterprise/EBITDA-1,136.41

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.1
Operating Margin-0.27

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.03

Income Statement

Revenue267.55B
Revenue/Share6,818.1
Gross Profit30.98B
EBITDA-36.2B
Net Income-53.88B
Diluted EPS-701.32

Balance Sheet

Total Cash1.1T
Total Cash/Share13,979.63
Total Debt402.11B
Total Debt/Equity0.22
Current Ratio4.48
Book Value Per Share25,807.11

Price History

52-Week Change-16.34
52-Week High58,700
52-Week Low35,800
Moving Average 50 Days47,930
Moving Average 200 Days45,600

Statistics

Average Volume128,076
Shares Outstanding78.37M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A